Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Whole Genome And Exome Sequencing Market Size Changed, over the years?

The market size of whole genome and exome sequencing has seen a significant increase in the past few years. It is projected to expand from a worth of $2.02 billion in 2024 to about $2.53 billion in 2025, experiencing a compound annual growth rate (CAGR) of 24.8%. This considerable growth during the historic period is linked to factors such as lessening sequencing expenses, an uptick in genetic disorders, clinical uses, genomic data repositories, and progress in bioinformatics.

How Much Will the Whole Genome And Exome Sequencing Market Be Worth in 2029?

Expectations are that the market size of whole genome and exome sequencing will experience significant expansion in the coming years, reaching $6.14 billion in 2029 with a CAGR of 24.9%. The prediction for growth during this period is largely due to factors such as population genomics initiatives, an increasing requirement for precision medicine, advancements in individual cell sequencing, the broadening scope of non-invasive prenatal tests (NIPT), and their application in studying rare diseases. Key trends anticipated during this forecast period encompass wider clinical adoption, swift progress in sequencing technologies, the emergence of populous scale genomic studies, the amalgamation of artificial intelligence and machine learning, and increasing applications within the field of oncology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

Which is the Largest Company in the Whole Genome And Exome Sequencing Market?

Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan

What Are the Main Market Drivers in the Whole Genome And Exome Sequencing Industry?

The increasing need for customized healthcare is projected to fuel the expansion of the whole genome and exome sequencing market. This sort of healthcare tailors to every patient’s unique needs considering their genetic, environmental, and lifestyle aspects. Whole genome and exome sequencing delivers a detailed analysis of one’s genetic constitution, thereby permitting custom-made healthcare plans based on individual genetics, environment, and lifestyle. As an example, the Personalized Medicine Coalition (PMC), a US organization that advocates for the understanding and incorporation of personalized medicine, stated in October 2022 that over 75,000 genetic testing products and 300 customized medicines are estimated to be available in 2022. Additionally, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) gave approval to 37 fresh molecular entities (NMEs) in 2022. Moreover, around 34% or 12 of the 35 therapeutic NMEs have been categorized as personalized. This escalating need for personalized treatments stimulates the growth of the market for whole genome and exome sequencing.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp

How Is the Whole Genome And Exome Sequencing Market Segments Structured?

The whole genome and exome sequencing market covered in this report is segmented –

1) By Product Type: Kits, Instruments

2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

What Strategic Trends Are Transforming the Whole Genome And Exome Sequencing Market?

Leading firms in the whole genome and exome sequencing market are concentrating on creating sophisticated technological innovations such as ultra-fast NGS (next-generation sequencing) analysis, in order to remain competitive. The ultra-fast NGS analysis is a breakthrough technology that allows for rapid processing of next-generation sequencing (NGS) data, drastically cutting the time it takes to analyze genomic data. In January 2023, for example, QIAGEN Digital Insights (QDI), a bioinformatics company based in the United States, unveiled their ultra-fast NGS analysis platform. This platform offers the ability to process an entire genome in 25 minutes at a cloud computing cost of $1, demonstrating its efficiency, affordability, and scalability. This significant technological advancement greatly improves the speed and accessibility of genomic data analysis, considerably impacting the whole genome and exome sequencing market by accelerating decision-making processes and increasing the acceptance of personalized medicine.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Which Global Regions Offer the Highest Growth in the Whole Genome And Exome Sequencing Market?

North America was the largest region in the whole genome and exome sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13957

This Report Delivers Insight On:

1. How big is the whole genome and exome sequencing market, and how is it changing globally?

2. Who are the major companies in the whole genome and exome sequencing market, and how are they performing?

3. What are the key opportunities and risks in the whole genome and exome sequencing market right now?

4. Which products or customer segments are growing the most in the whole genome and exome sequencing market?

5. What factors are helping or slowing down the growth of the whole genome and exome sequencing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model